Trial intelligence / Profile preview

Pharmacogenomics of Acitretin in Psoriasis Vulgaris

NCT02715960Phase 2Unknown

Sponsor
Central South University
Start
Dec 2015
Primary completion
Dec 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of acitretin in Psoriasis vulgaris (PV), sponsored by Central South University. Status: unknown.

02

Drugs

acitretin
03

Conditions

Psoriasis vulgaris (PV)

Beyond the preview

Go deeper on NCT02715960.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02715960.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call